Back to search

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.

Data up to Jan 2025

Published1994
Citations65
References38

Total Citations Per Year

Abstract

References (38)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1955 • 8,846 citations

Quantitative Determination of Serum Triglycerides by the Use of Enzymes

1973 • 3,206 citations

Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

1982 • 2,206 citations

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1988 • 1,722 citations

Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA

1973 • 1,457 citations

Determination of Lecithin: Cholesterol Acyltransfer in Human Blood Plasma

1971 • 559 citations

[24] Nondenaturing polyacrylamide gradient gel electrophoresis

1986 • 520 citations

Myopathy and Rhabdomyolysis Associated With Lovastatin-Gemfibrozil Combination Therapy

1990 • 422 citations

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia

1983 • 305 citations

Familial Combined Hyperlipidemia Workshop

1989 • 215 citations

Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

1990 • 210 citations

Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24

1991 • 188 citations

Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia

1993 • 166 citations

Role of triglycerides in coronary artery disease: Lessons from the prospective cardiovascular Münster study

1992 • 155 citations

Combination Drug Therapy for Familial Combined Hyperlipidemia

1988 • 127 citations

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteins

1990 • 118 citations

Pravastatin

1991 • 117 citations

Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.

1989 • 113 citations

Reverse cholesterol transport: Physiology and pharmacology

1991 • 112 citations

Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.

1984 • 100 citations

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: Evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

1992 • 91 citations

A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition

1992 • 78 citations

Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitors

1993 • 73 citations

Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia

1992 • 70 citations

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion

1993 • 69 citations

Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liver

1990 • 69 citations

Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia

1993 • 58 citations

Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition

1990 • 55 citations

Apolipoprotein AIMilano. Partial lecithin: Cholesterol acyltransferase deficiency due to low levels of a functional enzyme

1990 • 43 citations

Effects of storage on the distribution of high density lipoprotein subfractions in human sera

1985 • 39 citations

Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles

1988 • 33 citations

Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia

1991 • 27 citations

Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: Kinetic analysis using an integrated model

1986 • 26 citations

Isoelectric focusing of apolipoproteins in immobilized pH gradients: Improved determination of apolipoprotein Ephenotypes

1988 • 24 citations

Characterization of plasma lipids and lipoproteins in cholesteryl ester storage disease

1985 • 20 citations

Apolipoprotein A-II modulates HDL remodeling in plasma

1992 • 20 citations

Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment

1991 • 20 citations

Cited By (0)

Loading...
Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia… (1994) – Arteriosclerosis and Thrombosis A Journal of Vascular Biology | Metascience Observatory Explorer